Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Stem Cell Res ; 13(3 Pt A): 367-78, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25290189

ABSTRACT

Adipose tissue-derived stromal cells (ASC) form a rich source of autologous cells for use in regenerative medicine. In vitro induction of an endothelial phenotype may improve performance of ASCs in cardiovascular repair. Here, we report on an in vitro strategy using direct reprogramming of ASCs by means of ectopic expression of the endothelial-specific transcription factor SRY (sex determining region Y)-box18 (SOX18). SOX18 induces ASCs to express a set of genes involved in vascular patterning: MMP7, KDR, EFNB2, SEMA3G and CXCR4. Accordingly, SOX18 transduced ASCs reorganize under conditions of shear stress, display VEGF-induced chemotaxis and form tubular structures in 3D matrices in an MMP7-dependent manner. These in vitro findings provide insight into molecular and cellular processes downstream of SOX18 and show that reprogramming using SOX18 is sufficient to induce several endothelial-like features in ASCs.


Subject(s)
Adipose Tissue/cytology , Endothelial Cells/metabolism , SOXF Transcription Factors/metabolism , Stromal Cells/metabolism , Cell Differentiation , Cell Movement/drug effects , Cells, Cultured , Cellular Reprogramming , Chemotaxis/drug effects , Endothelial Cells/cytology , Genetic Vectors/genetics , Genetic Vectors/metabolism , Human Umbilical Vein Endothelial Cells , Humans , Matrix Metalloproteinase 7/metabolism , Microtubules/chemistry , Microtubules/metabolism , SOXF Transcription Factors/genetics , Shear Strength , Stromal Cells/cytology , Vascular Endothelial Growth Factor A/pharmacology
2.
Atherosclerosis ; 222(1): 208-15, 2012 May.
Article in English | MEDLINE | ID: mdl-22341865

ABSTRACT

OBJECTIVE: Exogenous insulin use in patients with type 2 diabetes (DM2) has been associated with an increased risk of cardiovascular events. Through which mechanisms insulin may increase atherosclerotic plaque vulnerability is currently unclear. Because insulin has been suggested to promote angiogenesis in diabetic retinopathy and tumors, we hypothesized that insulin enhances intra-plaque angiogenesis. METHODS: An in vitro model of pathological angiogenesis was used to assess the potential of insulin to enhance capillary-like tube formation of human microvascular endothelial cells (hMVEC) into a three dimensional fibrin matrix. In addition, insulin receptor expression within atherosclerotic plaques was visualized in carotid endarterectomy specimens of 20 patients with carotid artery stenosis, using immunohistochemical techniques. Furthermore, microvessel density within atherosclerotic plaques was compared between 68 DM2 patients who received insulin therapy and 97 DM2 patients who had been treated with oral glucose lowering agents only. RESULTS: Insulin, at a concentration of 10(-8)M, increased capillary-like tube formation of hMVEC 1.7-fold (p<0.01). Within human atherosclerotic plaques, we observed a specific distribution pattern for the insulin receptor: insulin receptor expression was consistently higher on the endothelial lining of small nascent microvessels compared to more mature microvessels. There was a trend towards an increased microvessel density by 20% in atherosclerotic plaques derived from patients using insulin compared to plaques derived from patients using oral glucose lowering agents only (p=0.05). CONCLUSION: Exogenous insulin use in DM2 patients may contribute to increased plaque vulnerability by stimulating local angiogenesis within atherosclerotic plaques.


Subject(s)
Plaque, Atherosclerotic/metabolism , Receptor, Insulin/biosynthesis , Cells, Cultured , Endarterectomy, Carotid , Endothelium, Vascular , Humans , Insulin/adverse effects , Insulin/therapeutic use , Microvessels/cytology , Microvessels/physiology , Neovascularization, Pathologic/metabolism , Plaque, Atherosclerotic/pathology
3.
J Thromb Haemost ; 8(12): 2800-9, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20946180

ABSTRACT

BACKGROUND: Fibrin is a temporary matrix that not only seals a wound, but also provides a temporary matrix structure for invading cells during wound healing. Two naturally occurring fibrinogen variants, high molecular weight (HMW) and low molecular weight (LMW) fibrinogen, display different properties in supporting angiogenesis in vivo and in vitro. OBJECTIVES: This study was aimed at investigating the functional characteristics and molecular mechanisms of human microvascular endothelial cells (HMVECs) cultured on HMW and LMW fibrin matrices. METHODS AND RESULTS: HMVECs on HMW fibrin matrices showed increased proliferation and tube formation as compared with their counterparts on unfractionated and LMW fibrin. Degradation of HMW fibrin was markedly enhanced by the presence of HMVECs, that of LMW fibrin was enhanced only slightly. However, the expression levels of fibrinolysis-regulating proteins and integrins were similar. Subsequent microarray analysis revealed that the expression of 377 genes differed significantly between HMVECs cultured on HMW fibrin and those cultured on LMW fibrin. Among these genes, UNC5B, DLL4 and the DLL4-Notch downstream targets Hey1, Hey2 and Hes1 showed increased expression in HMVECs on LMW fibrin. However, pharmacologic and genetic (DLL4 small interfering RNA) inhibition of DLL4-Notch signaling blunted rather than enhanced proliferation and tube formation by HMVECs on both fibrin variants. CONCLUSIONS: Heterogeneity in naturally occurring fibrinogen strongly influences endothelial cell proliferation and tube formation, and causes alterations in gene expression, including that of DLL4-Notch. The higher fibrinolytic sensitivity of HMW fibrin in the presence of HMVECs contributes to increased tube formation. Although the expression of DLL4-Notch was altered, it did not explain the enhanced tube formation in HMW fibrin. This study provides new perspectives for biological and tissue engineering applications.


Subject(s)
Endothelium, Vascular/metabolism , Fibrinogen/physiology , Gene Expression Regulation/physiology , Cell Adhesion , Cell Proliferation , Cells, Cultured , Culture Media , Endothelium, Vascular/cytology , Endothelium, Vascular/enzymology , Extracellular Signal-Regulated MAP Kinases/metabolism , Fibrinogen/chemistry , Fibrinolysis , Humans , Integrins/metabolism , Molecular Weight , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Proto-Oncogene Proteins c-akt/metabolism
4.
Diabetologia ; 53(5): 966-70, 2010 May.
Article in English | MEDLINE | ID: mdl-20182859

ABSTRACT

AIMS/HYPOTHESIS: Negative effects on the progression of adenocarcinomas by hyperinsulinaemia and the insulin analogue glargine (A21Gly,B31Arg,B32Arg human insulin) have recently been suggested. Most actions of this insulin analogue have hitherto been explained by direct stimulation of growth potential of neoplastic cells and by its IGF-1 related properties. However, insulin-stimulated angiogenesis could be an additional factor involved in tumour progression and clinical outcomes associated with cancer. METHODS: Five types of human adenocarcinoma (breast, colon, pancreas, lung and kidney) were evaluated for the presence of insulin receptors (IRs) on angiogenic structures. In an in vitro angiogenesis assay, various commercially available insulin compounds were evaluated for their potential to increase capillary-like tube formation of human microvascular endothelial cells (hMVEC). Insulin compounds used were: human insulin, insulin lispro (B28Lys,B29Pro human insulin), insulin glargine and insulin detemir (B29Lys[e-tetradecanoyl],desB30 human insulin). RESULTS: Insulin receptors were found to be strongly expressed on the endothelium of microvessels in all evaluated adenocarcinomas, in addition to variable expression on tumour cells. Low or no detectable expression of IRs was seen on microvessels in extratumoral stroma. Incubation with commercially available insulin compounds increased capillary-like tube formation of hMVEC in vitro. CONCLUSIONS/INTERPRETATION: Our results suggest that all tested insulin compounds may stimulate tumour growth by enhancing local angiogenesis. Future studies need to confirm the association between insulin therapy in type 2 diabetes and tumour progression.


Subject(s)
Adenocarcinoma/metabolism , Endothelium, Vascular/metabolism , Epithelial Cells/metabolism , Insulin/analogs & derivatives , Insulin/metabolism , Neovascularization, Pathologic/metabolism , Receptor, Insulin/metabolism , Breast Neoplasms/metabolism , Cells, Cultured , Colonic Neoplasms/metabolism , Disease Progression , Female , Humans , Immunohistochemistry , Insulin-Like Growth Factor I/metabolism , Kidney Neoplasms/metabolism , Lung Neoplasms/metabolism , Male , Pancreatic Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...